摘要
The basis of modern pharmacology is the human ability to exploit the production of specialized metabolites from medical plants,for example,terpenoids,alkaloids,and phenolic acids.However,in most cases,the availability of these valuable compounds is limited by cellular or organelle barriers or spatio-temporal accumulation patterns within different plant tissues.Transcription factors(TFs)regulate biosynthesis of these specialized metabolites by tightly controlling the expression of biosynthetic genes.Cutting-edge technologies and/or combining multiple strategies and approaches have been applied to elucidate the role of TFs.In this review,we focus on recent progress in the transcription regulation mechanism of representative high-value products and describe the transcriptional regulatory network,and future perspectives are discussed,which will help develop high-yield plant resources.
基金
supported by National Key Research and Development Program of China(2023YFC3503900)
National Natural Science Fund of China(82073963
82204554)
Zhejiang Provincial Natural Science Foundation of China(LQ23H280010)
National Ten Thousands Program for Leading Talents of Science and Technology Innovation
National Young Qihuang Scholars Training Program
Zhejiang Provincial Program for the Cultivation of High Level Innovative Health Talents
The Science Research Fund of Administration of Traditional Chinese Medicine of Zhejiang Province(2023ZR089)。
